Tag:
Life Technologies
Latest Headlines
Latest Headlines
Illumina fights Roche bid with 'poison-pill' maneuver
A day after Roche's ( $RHHBY ) hostile $5.7 billion bid to scoop up Illumina ( $ILMN ) hit the news, investors are wagering that the maker of DNA sequencing machines will attract a better offer.
Life Technologies' latest DNA sequencer targets informatics 'bottlenecks'
Life Technologies ( $LIFE ) set the genomics world abuzz today with the announcement of its latest DNA sequencing machine based on the semiconductor tech that Life scooped up in its acquisition of Ion
Novartis' interest in buying Gen-Probe fizzles, WSJ reports
Novartis' appetite for deals is expected to grow in the near future, but the Swiss drug giant ($NVS) may no longer be interested in gobbling up diagnostic test provider Gen-Probe. After speculation
PerkinElmer, others ride 'wave' of genomic data going to the cloud
As genome sequencers produce increasing volumes of data for labs to manage, companies like PerkinElmer are seizing a market opportunity to provide services and technology for researchers to store and
Knome automates analysis of NGS data, evolves in genomics field
Knome wants to take the labor-intensive process of analyzing some data on sequenced genomes off a researcher's plate. And the start-up this week revealed the release of its latest software for
Roche, Novartis make MIT innovators list
MIT's Technology Review has unveiled its list of the top 50 innovators, and nine life science companies have made the list. Roche and Novartis are representing Big Pharma this year. Roche's work
New programming language will drive DNA
Bioinformatics scientists have built two logic gates for what they hope will become a new programming language for drug design as well as chemical and agricultural product engineering. The
Life Technologies inks $725M deal for Ion Torrent
Arming itself for a looming showdown with Illumina over the booming market for second-generation gene sequencing technologies, Life Technologies struck a deal to buy Ion Torrent for $375 million in
Life Technologies budgets $100M for synthetic biology deals
Lured into the promising field of synthetic biology, Life Technologies is striking a string of new deals intended to position the company as one of the primary providers of the research tools which
Danaher to pay $1.1B for two bioresearch tech companies
Danaher Corp. is paying $1.1 billion to buy up two companies which will significantly increase its presence in the business of marketing drug discovery tools. Once the deal is complete in the fourth
